在患有慢性脏疾病的患者中,用于静脉静脉治疗静脉静脉
Gal Sella1,2, Chloe Kharsa2, Mangesh Kritya2
1The Heart Center, Kaplan Medical Center, Rehovot, affiliated with the Hebrew University of Jerusalem, Israel.
Journal of the Society for Cardiovascular Angiography & Interventions
|November 21, 2025
概括
患有慢性脏病 (CKD) 的患者在进行静脉支臂治疗以治疗静脉支臂缩 (ISR) 后面临更高的风险. 这凸显了在这个高风险群体中管理重大心血管不良事件 (MACE) 的定制策略的必要性.
科学领域:
- 心脏病学 心脏病学
- 腎臟病學 (nephrology) 是一種醫學專業.
- 干预心脏病学 干预心脏病学
背景情况:
- 静脉静脉复缩 (ISR) 是冠状动脉干预的重大挑战.
- 患有慢性病 (CKD) 的患者具有独特的炎症反应和血管化.
- 血管支臂疗法正在重新考虑复发ISR.
研究的目的:
- 为了评估血管支臂治疗ISR的临床结果.
- 为了比较患有CKD和没有CKD的患者之间的结果.
主要方法:
- 对227名患者 (54名CKD患者,173名非CKD患者) 的回顾性分析,这些患者接受了针对ISR的血管支臂治疗.
- 脑衰竭定义为eGFR<60毫升/分钟/1.73米2,持续时间≥3个月.
- 主要终点:目标损伤重血管化 (TLR). 二级终点:主要不良心血管事件 (MACE),1年内全因死亡率.
主要成果:
- 慢性病患者的1年MACE发病率较高 (63.0%对32.9%,P=.0003),主要原因是TLR增加 (31.5%对17.9%,P=.038).
- 出血并发症仅发生在CKD组 (5.6%).
- 在CKD患者中,男性性别与较低的TLR风险相关 (HR 0.15,P=.010).
结论:
- 患有CKD的患者在针对ISR进行血管支臂治疗后经历了显着更糟糕的结果.
- 慢性瘤的炎症环境可能会抵消支臂治疗的益处,导致MACE和TLR的增加.
- 精细的干预策略和风险管理对于接受这种手术的CKD患者至关重要.
相关概念视频
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
249
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
249
01:28Chronic Kidney Disease III: Interprofessional Care
326
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
326
01:20Acute Kidney Injury V: Interprofessional Care
284
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
284
01:18Chronic Kidney Disease IV: Nursing Management
307
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
307
01:30Continuous Renal Replacement Therapy
768
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
768
01:19Imaging Studies VII: Vascular Imaging
294
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
294